| Website | origentherapeutic... |
| Category | BioTech |
| Phone | 650-558-6700 |
| Employees | |
| Founded | 1997 |
| Description | biotechnology company |
| TOTAL | $2M |
| FUNDING TOTAL | $2M |
| Grant, 10/07 National Institute of Standards and Technology | $2M |
Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also develops a technology platform based on the genetic engineering of chicken embryonic cells, which can be genetically modified in such a way that the introduced genes are stably expressed in adult birds. Origen Therapeutics, Inc. was incorporated in 1997 and is based in Burlingame, California.
